FDA Approves Gilotrif for Late-Stage NSCLC
The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late...
Read More
Lung Cancer
Standard-Dose Radiation Best for Stage III NSCLC
A phase III trial in patients with stage III non-small cell lung cancer (NSCLC) concludes that...
Read More
Does Lung Screening Change Risk Perceptions?
Lung cancer screening does not appear to change risk perceptions of the disease or smoking-related...
Read More
Anti-PD-L1 Drug Shows Promising Anti-Cancer Effects
A phase I expansion study of the investigational drug MPDL3280A — an engineered PD-L1 targeted...
Read More
ASCO 2013: Deciding When to Operate in Lung Cancer
The Particulars: In patients with lung cancer, studies suggest that comorbidities appear to...
Read More
Men’s Fitness in Middle Age Protects Against Cancer
Findings from a large, prospective 20-year study indicate that a high level of cardiovascular...
Read More
ATS 2013: Racial Disparities in NSCLC Surgery
The Particulars: Surgery is typically the indicated initial treatment of loco-regional non-small...
Read More
‘Big Tent’ of Science, Medicine at ATS 2013
PHILADELPHIA — As the multiple disciplines that make up pulmonary, critical care, and sleep...
Read More
Obesity: A Challenge in Lung Cancer Surgery
Among patients with primary lung cancer undergoing lobectomy, having a higher BMI appears to...
Read More
STS 2013: Identifying Small, High-Risk Lung Tumors
The Particulars: Currently, there is no reliable method for identifying pathologically staged,...
Read More
STS 2013: Feasibility Test of Volume Criteria for T Staging
Purpose: Size criteria have been used as a gold standard for a long time in cancer staging of all...
Read More
STS 2013: Tri-Modality Therapy for Superior Sulcus NSCLC
Purpose: Trimodality therapy incorporating preoperative chemotherapy (cisplatin-etoposide,...
Read More
Optimizing Resources in Lung Cancer Surgery
Performing routine needle biopsy of suspicious lung nodules in surgical candidates appears to have...
Read More
FDA Permits Marketing of Bio-Seal Lung Biopsy Tract Plug System
Reduces risk of collapsed lung following lung biopsy The U.S. Food and Drug Administration today...
Read More
CHEST 2012: Secondhand Smoke Can Impair Breathing Within Minutes
Heavy concentrations of secondhand smoke, such as those found in smoke-filled bars and cars, can...
Read More
FDA Approves Abraxane for Advanced NSCLC
Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved...
Read More
Quitting Smoking: 10-Year Trends
The CDC analyzed data on smoking cessation among 27,157 United States adults between 2001 and...
Read More
Predicting NSCLC Survival
A Mayo Clinic study has found that overall quality of life (QOL) measured at the time of a...
Read More
The 2012 ASCO Annual Meeting
New research was presented at the 2012 American Society of Clinical Oncology annual meeting from...
Read More
Misinterpreting Benefits of Cancer Screenings
According to results from a national survey, improved survival and increased detection of cancer...
Read More